WADA is overhauling its testing standards and organizational structure, revising blood collection protocols for 2026 while considering independent agencies to replace national anti-doping programs that have traditionally screened their own athletes. The shift aims to eliminate conflicts of interest where countries test their own competitors.
·WADA published revised 2026 International Standard with updated blood collection wait times for athletes
·Proposal under consideration to move dope testing from national agencies to independent organizations
·Current system allows countries to conduct their own athlete testing, creating potential bias
·Tramadol added to 2024 WADA Prohibited List
·Testing eligibility disputes continue, including recent cases involving repeated screening protocols
drawn from World Anti Doping Agency, The New York Times, Neurology® Journals, Hindustan Times · updated 53d ago